1-3 of 3
Reynald Lescarbeau
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Functional Characterization and Optimization of Switchable Allogeneic Chimeric Antigen Receptor T Cells for Targeting CD19 and CD20 in B Cell Malignancies

Johannes Spehr, Jan-Erik Meyer, Simon Loff, Anika Langer, Moritz Langer, Ben Boyerinas, Isabelle Le Mercier, Reynald Lescarbeau, Marc Cartellieri, Armin Ehninger
Journal: Blood
Blood (2023) 142 (Supplement 1): 2059.
https://doi.org/10.1182/blood-2023-180873
Published: 2023
Journal Articles

A Novel Strategy for Off-the-Shelf T Cell Therapy Which Evades Allogeneic T Cell and NK Cell Rejection

Yong Zhang, Surbhi Goel, Aaron Prodeus, Utsav Jetley, Yiyang Tan, John Averill, Utkarsha Ranade, Ishina Balwani, Ivy Dutta, Palak Sharma, Priya Venkatesan, Dai Liu, Matthew Roy, Daniel O′Connell, Simo M Arredouani, Marie Keenan, Reynald Lescarbeau, Birgit C Schultes
Journal: Blood
Blood (2021) 138 (Supplement 1): 1711.
https://doi.org/10.1182/blood-2021-152999
Published: 2021
Journal Articles

CRISPR/Cas9 Gene-Edited Hematopoietic Stem Cell Therapy for Sickle Cell Disease

Vionnie W. C. Yu, PhD, Yi Liu, PhD, Matthew Curran, Pu Zhang, MD, Jennifer Snead, PhD, Christian Schmedt, Yi Yang, PhD, Victor Guosheng Lin, William R Tschantz, PhD, Lisa Quinn, Carsten Russ, Scott Clarkson, Amy Janiak, Morag Stewart, PhD, Yanick Mulumba, Reynald Lescarbeau, Brad Murray, Jessica Seitzer, Walter Strapps, Hon-Ren Huang, Kevin Sloan, Craig S Mickanin, BS, Lloyd Klickstein, MD, Susan Stevenson
Journal: Blood
Blood (2017) 130 (Supplement 1): 535.
https://doi.org/10.1182/blood.V130.Suppl_1.535.535
Published: 2017